Avantor Inc

Healthcare · Medical Instruments & Supplies

15.40$ +4.2% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

Avantor Inc (AVTR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 11,596 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet AVTR
Line item	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	10,447	–	–	10,118	9,912	10,014	10,018	9,763	9,773	9,786	9,867	9,938	9,907	9,739	11,250	12,199	13,897	13,836	13,431	13,113	13,464	13,396	13,063	12,798	12,973	12,763	12,694	12,841	12,115	12,326	12,777	11,676	11,795	11,663	11,596
Current Assets	1,834	185	–	1,904	1,900	1,940	2,029	2,019	2,022	2,197	2,292	2,297	2,231	2,232	2,423	3,565	2,477	2,606	2,572	2,560	2,658	2,627	2,499	2,385	2,385	2,321	2,329	2,505	2,147	2,282	2,515	2,257	2,451	2,404	2,462
Cash	185	-185	–	172	185	144	165	174	187	346	415	371	287	173	223	1,426	302	284	238	266	373	295	236	237	263	235	273	285	262	316	449	252	365	279	307
Cash & Short-Term Investments	185	185	–	172	185	144	165	174	187	346	415	371	287	173	223	1,426	302	284	238	266	373	295	236	237	263	235	273	285	262	316	449	252	365	279	307
Receivables	875	–	–	940	931	981	1,002	983	989	1,041	984	1,037	1,113	1,202	1,269	1,185	1,222	1,345	1,270	1,231	1,218	1,277	1,216	1,150	1,150	1,130	1,129	1,088	1,035	1,096	1,149	1,078	1,075	1,105	1,139
Inventory	695	–	–	679	671	703	728	715	711	686	738	730	740	778	841	844	872	896	923	905	914	904	890	850	828	811	796	780	732	750	780	796	818	810	829
Property, Plant & Equipment	664	–	–	–	599	736	710	679	689	556	552	553	550	537	653	683	706	700	698	698	727	737	698	698	–	–	–	–	–	–	–	–	–	–	–
Goodwill	2,847	–	–	2,803	2,785	2,766	2,780	2,736	2,769	2,736	2,761	2,809	2,860	2,820	3,558	3,506	5,341	5,265	5,626	5,511	5,653	5,683	5,694	5,638	5,717	5,672	5,660	5,671	5,539	5,609	5,762	4,985	4,987	4,952	4,935
Intangible Assets	4,989	–	–	4,680	4,566	4,459	4,404	4,248	4,220	4,098	4,058	4,042	4,049	3,932	4,372	4,206	5,140	5,013	4,280	4,099	4,133	4,077	3,895	3,788	3,775	3,663	3,583	3,523	3,360	3,331	3,350	3,267	3,194	3,099	3,014
Total Liabilities	9,477	–	–	9,227	12,963	13,152	7,607	7,408	7,311	7,346	7,326	7,386	7,232	6,933	8,264	8,094	9,700	9,478	8,961	8,522	8,609	8,401	8,052	7,699	7,720	7,427	7,259	7,287	6,158	6,228	6,491	6,106	6,230	6,074	5,966
Current Liabilities	1,104	–	–	1,015	1,096	1,107	1,186	1,079	1,075	1,127	1,054	1,136	1,243	1,241	1,378	1,320	1,451	1,447	1,571	1,552	1,659	1,670	1,550	1,488	1,480	1,442	1,465	1,630	2,008	2,034	2,576	1,517	1,379	1,367	1,382
Short-Term Debt	109	–	–	39	142	44	196	41	94	14	14	14	26	27	40	37	45	45	246	281	364	325	314	336	260	299	258	230	821	828	1,254	220	31	37	37
Accounts Payable	542	–	–	505	557	565	578	556	560	611	581	625	679	706	755	699	755	818	799	769	758	766	687	656	626	573	657	674	663	680	709	692	742	736	743
Long-Term Debt	7,009	–	–	–	6,782	6,749	5,127	5,089	5,023	5,040	5,064	5,057	4,868	4,606	5,612	5,550	6,978	6,816	6,293	5,908	5,923	5,736	5,570	5,291	5,277	5,024	4,857	4,691	3,235	3,279	2,988	3,638	3,916	3,779	3,661
Shareholders' Equity	-2,620	970	–	892	-3,052	-3,138	2,411	2,356	2,462	2,440	2,541	2,552	2,674	2,806	2,986	4,105	4,197	4,358	4,470	4,591	4,855	4,995	5,011	5,099	5,253	5,336	5,435	5,553	5,957	6,098	6,286	5,570	5,565	5,589	5,630
Retained Earnings	-156	–	–	-185	-238	-248	-296	-274	-204	-158	-98	-140	-89	75	233	390	484	674	862	1,029	1,170	1,292	1,285	1,393	1,492	1,552	1,645	1,703	2,203	2,268	2,332	1,620	1,673	1,716	1,754
Shares Outstanding	400	497	497	497	491	426	323	581	582	581	582	577	587	589	591	598	619	681	680	679	677	678	675	679	679	681	683	683	683	682	682	682	679	679	677

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings